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Warburg micro syndrome (WARBM) is a genetic heterogeneous disease characterized by microcephaly, intellectual
disability, brain, ocular, and endocrine anomalies. WARBM1-4 can be caused by biallelic mutations of the RAB3GAP1
(RAB3 GTPase-activating protein 1), RAB3GAP2, RAB18 (RAS-associated protein RAB18), or TBC1D20 (TBC1 domain
protein, member 20) gene, respectively. Here, we delineate the so far largest intragenic homozygous RAB3GAP1
microdeletion. Despite the size of the RAB3GAP1 gene deletion, the patient phenotype is mainly consistent with that
of other WARBM1 patients, supporting strongly the theory that WARBM1 is caused by a loss of RAB3GAP1 function.
We further highlight osteopenia as a feature of WARBM1.
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Warburg micro syndrome (WARBM) is a rare autosomal
recessive disorder characterized by neurodevelopmental
abnormalities such as congenital or postnatal microcephaly,
severe intellectual disability, pachy- or polymicrogyria,
and hypoplasia/agenesis of the corpus callosum as well as
ocular manifestations including congenital cataract, micro-
cornea, microphthalmia, and optic atrophy [1-3]. Further
features of WARBM comprise hypothalamic hypogonadism,
epilepsy, limb spasticity, and joint contractures. WARBM1
(MIM#600118) is caused by biallelic mutations of the
RAB3 GTPase-activating protein 1 gene RAB3GAP1 (2q31;
MIM*602536), WARBM2 (MIM#614225) by mutations of
the RAB3 GTPase-activating protein 2 gene RAB3GAP2
(1q41; MIM*609275), WARBM3 (MIM#614222) by muta-
tions of the RAS-associated protein RAB18 gene RAB18
(10p12.1; MIM*602207), and WARBM4 (MIM#615663) by
mutations in the TBC1 domain protein, member 20, gene
TBC1D20 (MIM*611663). Most mutations were predicted to
result in nonsense-mediated mRNA decay and/or loss-of-* Correspondence: angela.kaindl@charite.de
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article, unless otherwise stated.protein-function [1,2,4-7], putatively explaining the lack of
a genotype-phenotype correlation. We here report the lar-
gest RAB3GAP1 gene microdeletion to date in patients
with WARBM1 and compare their phenotype with that of
other WARBM1 patients. The two index patients were
born at term without complications as the first and second
child of healthy, consanguineous parents of Kurdish-
Armenian descent (Figure 1). Pregnancies were uneventful,
and anthropometric data in the first months of life were
reported to be normal by the parents. Both patients were
diagnosed with bilateral cataracts in the first months of life,
and cataract surgery was performed in patient IV.2. The
parents noted progressive hypotonia with loss of head
control and finally developmental delay when their child
did not attempt to roll within the first year of life. At first
presentation at 6 (IV.1) and 5 (IV.2) years-of-age, the
patients were not able to roll over, sit, stand, or speak,
exhibited a short stature, dystrophy, and microcephaly
(IV:1: height 90 cm, 16 cm <3. centile, −5.2 SD; weight
11 kg, 4 kg <3. centile, −3.4 SD; head circumference 47 cm,
1.5 cm <3. centile, −2.6 SD; IV.2: height 95 cm, 6 cm <3.
centile, −3.3 SD; weight 10,3 kg, 5 kg <3. centile, −3.7 SD;
head circumference 45 cm, 4 cm <3. centile, −3.8 SD), and
had bilateral cataracts (unilateral iatrogenic aphakia in
IV.2), microcornea, and microphthalmia. Bilateral crypt-
orchidism was present in IV.2. In both patients, poor headntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Figure 1 (See legend on next page.)
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Figure 1 Phenotype of the index patients with WARBM1. (A) Pedigree. (B) Pictures of the index patients illustrating severe dystrophy,
microcephaly, and distal contractures. Facial features include a prominent nasal root, relatively short nose, large ears, and a mild facial hypertrichosis.
(C) Appropriate skeletal age but severe osteopenia on conventional X-rays of left hand of patient IV.2 when compared to an age- and sex-matched
control. (D-G) Cranial MRI of patient IV.2 revealed parietal pachygyria (D, axial T2), widened sylvian fissure (E, axial T2), cerebellar atrophy (F, coronal T2),
and corpus callosum dysmorphism with agenesis of the splenium corpi (G, sagittal T2). (H) Scheme depicts all previously reported mutations in the
RAB3GAP1 gene in patients with WARBM1 and the novel deletion in our index patients.
Table 1 Comparison of phenotypic features of the index patients with those described in other patients with Warburg
micro syndrome 1–3 and Martsolf syndrome
Characteristics and symptoms HPO ID Patient Patient WARBM1 WARBM2 WARBM3 MS
Pedigree ID II.1 II.2
Gender Female Male
Age at last assessment (years) 5.9 4.5
Growth
Short stature 0004322 + + + + + +
Postnatal failure to thrive 0001508 + + + + + +
Growth hormone deficiency 0000824 + + NR NR NR +
Head and neck
Postnatal microcephaly 0000252 + + + + + (+)
Micrognathia 0000347 + - + - - +
Large ears 0000400 - + + + - -
Microphthalmia 0000568 + + + + + +
Microcornea 0000482 + + + + + +
Congenital cataract 0000519 + + + + + +
Ptosis 0000508 - - (+) - - -
Nystagmus 0000639 - - (+) - - -
Epicanthal folds 0000286 - - - - - +
Genitourinary
Cryptorchism 0086889 NA + + + + +
Hypogenitalism 0003241 - + + + + +
Skeletal
Osteoporosis 0000939 ++ ++ NR NR NR NR
Kyphoscoliosis 0002751 + + + NR + +
Joint hypermobility 0001382 - - (+) - - -
Joint contractures 0002803 + + + + + -
Foot deformities 0001760 - - + + - +
Hair
Facial hypertrichosis 0002219 + + + - - -
Neurologic
Intellectual deficit 0001249 ++ ++ ++ ++ ++ +
Optic atrophy 0000658 + + + + + -
Hyperreflexia 0007034 + + + + + +
Muscular hypotonia 0001290 + + + + + +
Spastic diplegia 0001264 + + + + + (+)
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Table 1 Comparison of phenotypic features of the index patients with those described in other patients with Warburg
micro syndrome 1–3 and Martsolf syndrome (Continued)
Seizures 0001250 - - + - + -
Inability to walk 0002540 + + + + + (+)
Absent speech 0001344 + + + (+) + (+)
Cranial MRI
Abnormal corpus callosum 0001273 + + + + + (+)
Cerebral atrophy 0002059 - - + (+) + (+)
Cerebral malformations 0007319 - - + - - -
Polymicrogyria 0002126 - - + (+) + (+)
Pachygyria 0001302 + + + - - -
Enlarged sylvian fissures 0100952 + + + - + (+)
Cerebellar hypoplasia 0001321 + + + (+) + -
Dysmyelination 0007266 - - + (+) + -
Cardiovascular
Cardiomyopathy 0001638 - - NR NR NR +
Cardiac failure 0001635 - - NR NR NR +
Respiratory
Recurrent infections 0002205 - - NR NR NR +
All symptoms are listed according to the nomenclature and the systematics of the OMIM “Clinical Synopsis” and the Human Phenotype Ontology (HPO [14]).
Abbreviations: +, present; −, not present; (+) mild or rare; ++, severe; NA, not applicable; NR, not reported; HPO, human phenotype ontology; WARBM1-3, Warburg
micro syndrome 1–3; MS, Martsolf syndrome.
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thoracolumbar scoliosis, lower-limb-spasticity and con-
tractures, and unilateral hip dislocation were apparent.
Cranial MRI revealed bilateral parietal pachygyria,
dysgenesis of the corpus callosum with agenesis of the
splenium, prominent fissura sylvii, mild cerebellar atrophy,
and hypotrophic optic chiasma in both patients (Figure 1,
Additional file 1: Figure S1). Their short stature was
associated with severe osteopenia, mild growth hormone
deficiency (levels −2.2 to −3 SDS), but appropriate bone
age and normal calcium, phosphate, alkaline phosphatase
serum levels (Figure 1). Vitamin D supplementation over
8 months did not improve osteopenia.
We identified the largest intragenic RAB3GAP1 micro-
deletion published to date in the index patients through
combined Sanger sequencing and array CGH (arr[hg19]
2q21.3(135.837.294 × 2,135.857.789 - 135.872.940 ×
0,135.896.068 × 2) and arr[hg19]4p16.3(68.185×2,72.477-
156.130×1,165.852×2)) and further characterized the dele-
tion breakpoints using multiple PCR amplicons (Figure 1,
Additional file 2: Supplemental Data). The additional small
4p16.3-deletion, containing parts of the genes ZNF718 and
ZNF595 is likely not relevant for the phenotype of the
patients. The deletion is very small, encompassing only
84 kb, and overlaps with deletions documented in the
normal population in the database of genomic variants
(DGV). All deletions listed in decipher affecting the
respective chromosome are vastly larger. Moreover,
both corresponding genes have not been associatedwith clinical phenotypes (search in: OMIM, PubMed,
Uniprot, Genecards). However, we confirmed a homo-
zygous 2q21.3-deletion of 50.4 kb encompassing exons
4–15 of RAB3GAP1 corresponding to about 45% of the
coding gene sequence: 135,840,320-135,891,847 (hg 19)
in both patients, which is heterozygous in the parents
as shown by qPCR. The extensive size of the patients´
deletion, their phenotypes resemble previous descrip-
tions of WARBM1 (Table 1), thereby firmly supporting
the theory that all WARBM1 phenotypes are caused by
a loss of RAB3GAP1 function and/or by nonsense-
mediated mRNA decay. Surprisingly, some WARBM1-
associated neuro-ophthalmological anomalies were absent
in our patients, such as ptosis and nystagmus, delayed
myelination, cerebral atrophy, and seizures [1,2,8-11]. Such
mild phenotypic variability of WARBM1 is not well
understood.
Osteopenia present in our patients has not been
highlighted in WARBM so far. While osteopenia can
result from vitamin D deficiency, it may also be caused
by RAB3GAP1 dysfunction itself as RAB3GAP1 arrests
the activity of the osteoclastic bone resorption promoter
RAB3D [12]. Uncontrolled activity of the latter is associ-
ated with bone structure defects in humans [12]. Osteo-
penia through RAB3GAP1 deficiency is supported by
(i) the serum findings in our patients arguing against a
severe rachitis secondary to vitamin D deficiency and
(ii) the ineffectiveness of vitamin D supplementation
with respect to osteopenia in the patients.
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deletion of 45% of RAB3GAP1 provokes a rather typical
WARBM1 phenotype. We thereby strongly support the
theory that all truncating RAB3GAP1 mutations generate
a loss-of-protein-function and/or nonsense-mediated-
mRNA-decay and therefore result in a similar phenotype.
Only hypomorphic RAB3GAP1 mutations induce the
milder Martsolf syndrome phenotype [5,9,13]. Severe
osteopenia needs to be considered as a feature of
WARBM, and future insight into the role of RAB3D in
WARBM may help to understand skeletal abnormalities
and assist in establishing a therapeutic approach.
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